Whether your personal interests are in supporting innovation, bringing lifesaving biomedical products to patients, training the next generation of biomedical leaders or fueling our economy, the Center for Biotechnology provides a vehicle to accomplish great things. Things that matter. Things that change, and save, lives.
Your involvement is an essential part of our future. Please consider a gift to the Center for Biotechnology which will help fuel innovation by ensuring that lifesaving technologies make it out of research labs and into the hands of patients.
Give to the Center for Biotechnology online through the Stony Brook Foundation. Contributions can be made to our Fund for Excellence. More information about donating through the Stony Brook Foundation can be found here.
The Long Island Network for Clinical and Translational Science (LINCATS) is awarding pilot funding of up to $25K per investigator with projects of novel approaches to translational science. This is open to faculty and postdoctoral fellows from the LINCATS network. Up to 8 awards will be granted per year – 4 of which will be provided to principal investigators from collaborating institutions, and 4 for SBU investigators.
Eligibility: All postdoctoral fellows and faculty affiliated with the LINCATS network (Brookhaven National Laboratory, Cold Spring Harbor, Northport VA Medical Center, Stony Brook University and all Stony Brook Medicine-affiliated healthcare locations) are eligible to apply. We will prioritize early career, under-represented groups, women, health disparities-focused clinical and translational science, and collaborative projects across institutions. Preference will be given to non-funded and new lines of research for the applying investigator.
Awardees will also benefit from research support from our Research Concierge, providing aid in:
Regulatory submission through approval Data Capture and OnCore subject tracking Pilot Tracking, to ensure the project meets specified milestones, including timely reporting Resource Access to all LINCATS services Monitoring and projecting study budgets
Attention Stony Brook University Faculy and Staff: Applications for the second cycle of the President’s Fast Impact Fund (FIF) opened August 3, 2026. Open to all Stony Brook faculty and staff, this special initiative supports immediate-impact projects that can be launched quickly and deliver results within six to ten months.
The FIF provides awards of up to $300,000 focused on low‑investment, high‑reward initiatives that create visible, positive change. Examples of projects that would be considered include specialized equipment or technology acquisitions, pilot programs or proof‑of‑concept initiatives, targeted renovations or seed funding, among other opportunities.
All proposals must include a customized, high-level budget and be endorsed by the relevant vice president or dean with authority to implement the project. Applications for the August cycle will be available beginning August 3 with submissions due Friday, August 21 by 5 pm, ET. Please visit the Fast Impact Fund website for additional information and to submit an application.
Envisagenics, supported by the Center for Biotechnology at Stony Brook University, is a pioneering biotech company that has been applying AI to drug target discovery for over a decade. In drug development, targets are molecular structures (often proteins) where drugs bind to exert their therapeutic effects. For cancer, an ideal target is a cell-surface protein found exclusively on tumor cells but not in healthy tissues.
[post_title] => NYSTAR-supported AI Advancements Make Strides in Fight Against Cancer
[post_excerpt] =>
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => nystar-supported-ai-advancements-make-strides-in-fight-against-cancer
[to_ping] =>
[pinged] =>
https://fuzehub.com/manufacturing-blog/nystar-supported-ai-advancements-make-strides-in-fight-against-cancer/
[post_modified] => 2026-08-04 11:15:19
[post_modified_gmt] => 2026-08-04 15:15:19
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://centerforbiotechnology.org/?p=4899
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[2] => WP_Post Object
(
[ID] => 4534
[post_author] => 4
[post_date] => 2024-04-08 13:47:00
[post_date_gmt] => 2024-04-08 17:47:00
[post_content] =>
The Center for Biotechnology has announced the appointment of Dr. Dee Dao as Associate Director for Business Development and Investment. In her new role, Dr. Dao will serve as the primary contact on issues related to research, technology development and commercialization for the Center for Biotechnology. Additionally, Dr. Dao will foster new collaborative relationships in order to bolster sponsored research agreements and strategic alliances.
Prior to joining the CFB, Dr. Dao served as a Venture Associate for the NYU Innovation Venture Fund, where she focused on investment opportunities in life science and healthcare. Prior to NYU, Dr. Dao was at the Ludwig Institute for Cancer Research where she contributed to early oncology therapeutic development planning and oversaw intellectual property (IP) strategy to support the clinical development of the Institute’s therapeutics. Before that, Dr. Dao investigated bacterial virulence and immunity to identify new vaccines against Tuberculosis as a postdoctoral fellow in an HHMI laboratory at Albert Einstein College of Medicine.
Currently, Dr. Dao also serves as a mentor for entrepreneurs participating in the Entrepreneurship Lab, a NYCEDC initiative. Dr. Dao received a Ph.D. in Molecular Genetics/Developmental Biology at Columbia University and a B.S. in Chemistry from University of Pittsburgh. Dr. Dao is also an alumnus of the Center for Biotechnology’s Fundamentals of the Bioscience Program in 2010.
“We are thrilled to have Dee join the Center for Biotechnology to lead our technology and business development efforts on behalf of innovators and emerging companies in New York” Diane Fabel, Director of Operations at the Center for Biotechnology said. She continued “Dee brings deep experience working with and funding innovation to her role at the Center which our clients and community will greatly benefit from.”
“I am very happy to join the team at the Center for Biotechnology. I’ve admired the work the Center for Biotechnology has done when it comes to supporting and accelerating the development of biomedical technology in New York State” Dr. Dao said. “I’m looking forward to helping lead the technology and business development efforts of the Center and increase the impact the organization can have on the wealth of innovations in the region”.
[post_title] => Dr. Dee Dao Appointed Associate Director for Business Development
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => dr-dee-dao-appointed-associate-director-for-business-development
[to_ping] =>
[pinged] =>
[post_modified] => 2025-02-24 12:42:43
[post_modified_gmt] => 2025-02-24 17:42:43
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://centerforbiotechnology.org/?p=4534
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[3] => WP_Post Object
(
[ID] => 3640
[post_author] => 4
[post_date] => 2020-10-16 14:49:58
[post_date_gmt] => 2020-10-16 14:49:58
[post_content] =>
Stony Brook University's Office of Technology Licensing and Industry Relations (OTLIR) has unveiled a new website allowing users easy access to important marketing information about SBU inventions, including images, technology descriptions, names of inventors, patent and licensing status, and technology licensing contacts. Users may browse by category, or search by keyword to find any particular technology, topic, or inventor. Visit the newInnovation site here: https://www.stonybrook.edu/technology-licensing/innovations/
Attention Stony Brook University Faculy and Staff: Applications for the second cycle of the President’s Fast Impact Fund (FIF) opened August 3, 2026. Open to all Stony Brook faculty and staff, this special initiative supports immediate-impact projects that can be launched quickly and deliver results within six to ten months.
The FIF provides awards of up to $300,000 focused on low‑investment, high‑reward initiatives that create visible, positive change. Examples of projects that would be considered include specialized equipment or technology acquisitions, pilot programs or proof‑of‑concept initiatives, targeted renovations or seed funding, among other opportunities.
All proposals must include a customized, high-level budget and be endorsed by the relevant vice president or dean with authority to implement the project. Applications for the August cycle will be available beginning August 3 with submissions due Friday, August 21 by 5 pm, ET. Please visit the Fast Impact Fund website for additional information and to submit an application.